Publications by authors named "Callaghan O"

Phenylethylamine and its monomethylated derivatives p-methylphenylethylamine, α-methylphenylethylamine, phenylethylamine itself, N-methylphenylethylamine, o-methylphenylethylamine, and β-methylphenylethylamine, readily cross the blood-brain barrier showing a brain-uptake index (%) ± SD (water considered 100 %), of 108 ± 11, 98 ± 14, 83 ± 6, 78 ± 11, 62 ± 7 and 56 ± 6, respectively (injection of tritiated water and 100 μg standard amine, which was measured by gas-liquid chromatography). Similar brain-uptake index values (determined by double isotope counting) were obtained for phenylethylamine and α-methylphenylethylamine (amphetamine) after the injection of tritiated water and C(14)-labeled amine (either 3 μg or when added 100 μg standard compound), suggesting that they entered the brain via passive diffusion. Accordingly, both amines distributed rather evenly in the various rat brain areas examined: uptake index (%) ± SD (double isotope counting; non-, and diluted labeled amine) for phenylethylamine (89 ± 8 and 78 ± 7, 83 ± 9 and 86 ± 9, 96 ± 6 and 84 ± 7) and for α-methylphenylethylamine (88 ± 11 and 87 ± 9, 93 ± 14 and 87 ± 11, 97 ± 12 and 87 ± 9) for the cerebellum, frontal cortex, and striatum, respectively.

View Article and Find Full Text PDF

Eighteen male cluster headache (CH) inpatients within a CH series participated in this research. Blood samples were drawn from patients at least 6-hour pain-free after the last acute CH episode and then shortly prior (SP), during, and soon after (SA) a new acute CH attack. Three healthy male, age-comparable drug-free volunteers served as controls; 5 samples were obtained from each of these individual over a 24-hour period.

View Article and Find Full Text PDF
Article Synopsis
  • * An aminopyrimidine was found to have high micromolar affinity, which was then improved through structure-based design into a more effective low nanomolar compound.
  • * A fragment with phenolic structure was also optimized to achieve subnanomolar affinity for Hsp90, demonstrating a remarkable 1,000,000-fold increase in affinity with minimal modifications, leading to a compound currently in clinical trials for cancer treatment.
View Article and Find Full Text PDF
Article Synopsis
  • Fragment-based lead discovery was used to develop inhibitors for urokinase-type plasminogen activator (uPA), starting with the drug mexiletine (R)-5.
  • Through structure-aided design, researchers created enhanced inhibitors that maintained crucial interactions while increasing potency by targeting additional areas of the active site.
  • The final optimized compound, designated as 15, emerged as a strong, selective, and orally bioavailable uPA inhibitor.
View Article and Find Full Text PDF
Article Synopsis
  • - Fragment-based lead generation successfully identified a new series of cyclic amidine inhibitors for beta-secretase (BACE-1), starting with initial compounds that showed millimolar activity through NMR screening.
  • - Efforts to improve these fragments involved structure-guided techniques using X-ray crystallography and potency testing, resulting in the development of stronger micromolar inhibitors.
  • - Further optimization led to the discovery of dihydroisocytosines, achieving submicromolar potency with Compound 29 being the most promising candidate with an IC50 of 80 nM for future research.
View Article and Find Full Text PDF
Article Synopsis
  • Fragment-based lead discovery has been effectively used to target the enzyme BACE-1, which is an aspartyl protease important in various biological processes.
  • Initial fragment hits featured an aminopyridine motif that binds to key catalytic aspartic acid residues in the enzyme's active site.
  • Through structure-based design, low micromolar lead compounds have been developed, with compounds 4 and 6c showing IC50 values of around 25 microM, and optimized compound 8a achieving a significantly lower IC50 of 690 nM.
View Article and Find Full Text PDF
Article Synopsis
  • The paper discusses using fragment screening and high-throughput X-ray crystallography to identify potential inhibitors of the beta-secretase enzyme (BACE-1), which is related to Alzheimer's disease.
  • Three unique chemotypes were found to bind to the enzyme's active site: aminoheterocycles, piperidines, and aliphatic hydroxyl groups, although they were weak inhibitors.
  • A novel recognition motif was discovered in aminoheterocycles, leading to the identification of a more potent aminopyridine compound and advancements in drug design for developing stronger inhibitors.
View Article and Find Full Text PDF

1. Rat liver 100,000 g pellet microsomal fraction p-hydroxylate phenylethylamine to tyramine in a relatively slow proceeding, NADPH-requiring reaction; Km 2.1 x 10(-5) M and Vmax 0.

View Article and Find Full Text PDF

1. Incubation of [3H]tyrosine methionine-enkephalin (6 x 10(-9) M final concentration) with human platelet-poor plasma (1:9 ratio to Trizma Base buffer, pH 7.4) results mostly (greater than 95%) in hydrolysis of the tyrosyl-glycine peptide bond.

View Article and Find Full Text PDF

Human brain preparations obtained from either the putamen, thalamus, hippocampus or lateral occipital gyrus p-hydroxylate phenylethylamine to tyramine, a reaction carried out by a microsomal (100,000 xg pellet) membrane bound, NADPH-requiring enzyme. This is a minor metabolic pathway occurring in chronic psychiatric patients, as well as in age-comparable controls.

View Article and Find Full Text PDF

One hundred successive infants weighing less than 1500 g at birth were allocated alternately to intermittent nasogastric or continuous nasoduodenal feeding regimens. Eighty were appropriate for gestational age, and of these 25 fed successfully by nasogastric tube and 16 tolerated nasoduodenal feeding until 1600 g. No significant differences in either calorie intake or growth rates were identified throughout the seven weeks of the study.

View Article and Find Full Text PDF

The activity of blood platelets monoamine oxidase (MAO) was significantly reduced in a group of insulin-dependent diabetics when compared to sex- and age-matched controls. This enzymatic change was accompanied by a dramatic increase in the plasma levels of phenylethylamine, whereas no significant changes were observed for the concentration of either p-tyramine or phenylethanolamine. Levels of the o- and m-isomers of tyramine were below detectable limits (less than 0.

View Article and Find Full Text PDF

Three watersheds, varying from highly polluted or moderately polluted to essentially pollution-free, were surveyed to determine the frequency of fish disease. Over a five year period, it was found that a relationship existed between the level of pollution and frequency of disease. The occurrence rates of microbial and oncogenic diseases increased similarly in relation to increases in pollution in the waters.

View Article and Find Full Text PDF

The in vivo and in vitro effects of various monoamine oxidase inhibitors (MAOI) on the borohydride stabilizable finding of serotonin (5-HT) or tryptamine in brain was investigated. A significant correlation between the extent of Mao inhibition and the amount of stabilized binding of the indolealkylamines was demonstrated. All hydrazine-type MAOI and harmine, a reversible nonhydrazine-type MAOI, employed in vitro, were shown to decrease the binding.

View Article and Find Full Text PDF

The competitive effect of 5,6-dihydroxytryptamine, morphine and chlorpromazine on the binding of serotonin (5-HT) to rat brain slices was investigated. Ths busynaptosomal localization of the binding of morphine in bovine midbrain preparations was compared to that of 5-HT and found to be considerably higher. The condensation of 5-HT and tryptamine receptor carbonyl groups in brain with phenylisopropylhydrazine was shown in vitro and vivo.

View Article and Find Full Text PDF

The subsynaptosomal distribution of the borohydride stabilizable binding of serotonin (5-HT) in the brain was investigated using various enzyme markers, such as NAD glycohydrolase (NADase), Na+, K+-activated ATPase for synaptic membranes, and monoamine oxidase (MAO) for outer mitochondrial membranes. The gross distribution of the activity of NADase and Na+, K+-activated ATPase in various membrane fractions was found to parallel the distribution of 5-HT binding in these fractions. Radioactivity bound to brain fractions was extractable with chloroform-methanol (2:1).

View Article and Find Full Text PDF